Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
Sertraline
Pfizer Healthcare Ireland
N06AB; N06AB06
Sertraline
100 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Selective serotonin reuptake inhibitors; sertraline
Marketed
1991-08-19
Page 1 of 11 2020-0061861, 2020-0061654 PACKAGE LEAFLET: INFORMATION FOR THE USER LUSTRAL® 50 MG FILM COATED TABLETS LUSTRAL® 100 MG FILM COATED TABLETS Sertraline READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Lustral is and what it is used for 2. What you need to know before you take Lustral 3. How to take Lustral 4. Possible side effects 5. How to store Lustral 6. Contents of the pack and other information 1. WHAT LUSTRAL IS AND WHAT IT IS USED FOR Lustral contains the active substance sertraline. Sertraline is one of a group of medicines called Selective Serotonin Re-uptake Inhibitors (SSRIs); these medicines are used to treat depression and/or anxiety disorders. Lustral can be used to treat: Depression and prevention of recurrence of depression (in adults). Social anxiety disorder (in adults). Post traumatic stress disorder (PTSD) (in adults). Panic disorder (in adults). Obsessive compulsive disorder (OCD) (in adults and children and adolescents aged 6-17 years old). Depression is a clinical illness with symptoms like feeling sad, unable to sleep properly or to enjoy life as you used to. OCD and Panic disorders are illnesses linked to anxiety with symptoms like being constantly troubled by persistent ideas (obsessions) that make you carry out repetitive rituals (compulsions). PTSD is a condition that can occur after a very emotionally traumatic experience, and has some symptoms that are similar to depression and anxiety. Social anxiety disorder (social phobia Lesen Sie das vollständige Dokument
Health Products Regulatory Authority 12 February 2021 CRN009XF5 Page 1 of 16 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lustral 100 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains Sertraline hydrochloride equivalent to 100 mg sertraline. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Sertraline 100 mg film-coated tablets are white, capsular shaped (13.1 x 5.2 mm), film-coated tablets marked ‘ZLT 100’ on one side and ‘PFIZER’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sertraline is indicated for the treatment of: Major depressive episodes. Prevention of recurrence of major depressive episodes. Panic disorder, with or without agoraphobia. Obsessive compulsive disorder (OCD) in adults and paediatric patients aged 6-17 years. Social anxiety disorder. Post traumatic stress disorder (PTSD). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Initial treatment_ _Depression and OCD_ Sertraline treatment should be started at a dose of 50 mg/day. _Panic Disorder, PTSD, and Social Anxiety Disorder_ Therapy should be initiated at 25 mg/day. After one week, the dose should be increased to 50 mg once daily. This dosage regimen has been shown to reduce the frequency of early treatment emergent side effects characteristic of panic disorder. _Titration_ _Depression, OCD, Panic Disorder, Social Anxiety Disorder and PTSD _ Patients not responding to a 50 mg dose may benefit from dose increases. Dose changes should be made in steps of 50 mg at intervals of at least one week, up to a maximum of 200 mg/day. Changes in dose should not be made more frequently than once per week given the 24-hour elimination half life of sertraline. The onset of therapeutic effect may be seen within 7 days. However, longer periods are usually necessary to demonstrate therapeutic response, especially in OCD. _Maintenance_ Health Products Regulatory Authority 12 February 2021 CRN009XF5 Page 2 of 16 Dosage duri Lesen Sie das vollständige Dokument